Morfin F, Thouvenot D, Aymard M, Souillet G
Laboratory of Virology, Hospices Civils de Lyon, Lyon, France.
J Med Virol. 2000 Oct;62(2):247-50.
HSV infections are treated efficiently and prevented by acyclovir, although resistant strains have been reported. Resistance to acyclovir involves mainly mutations in the viral gene encoding thymidine kinase; mutations may lead to an altered or, more frequently, deficient TK. These acyclovir-resistant TK deficient strains are not able to reactivate from a latent infection in an experimental model, compared to TK positive strains. A case is reported of a bone marrow transplant child who developed HSV infection at 11 days post-transplantation. Acyclovir-resistant HSV 1 was isolated on day 19 post-transplantation. The patient was cured of his infection. A resistant virus was detected 20 months later that harboured the same TK gene mutation as the first resistant virus. This mutation is an insertion of one guanine in a homopolymer repeat of seven guanines located at codon 146 of TK. It has previously been reported and associated with the expression of a deficient TK activity and the ability to reactivate in mice. These results corroborate the clinical relevance of this mutation, which is associated with acyclovir-resistant recurrent infections in humans.
虽然已有耐药菌株的报道,但阿昔洛韦能有效治疗和预防单纯疱疹病毒(HSV)感染。对阿昔洛韦的耐药性主要涉及编码胸苷激酶的病毒基因发生突变;这些突变可能导致胸苷激酶改变,更常见的是功能缺陷。与胸苷激酶阳性菌株相比,这些对阿昔洛韦耐药的胸苷激酶缺陷菌株在实验模型中无法从潜伏感染中重新激活。本文报道了1例骨髓移植儿童,在移植后11天发生HSV感染。移植后第19天分离出对阿昔洛韦耐药的HSV-1。该患者感染已治愈。20个月后检测到一种耐药病毒,其携带与第一种耐药病毒相同的胸苷激酶基因突变。该突变是在胸苷激酶第146密码子处由7个鸟嘌呤组成的同聚物重复序列中插入了1个鸟嘌呤。此前已有报道,该突变与胸苷激酶活性缺陷的表达以及在小鼠体内重新激活的能力有关。这些结果证实了该突变的临床相关性,其与人类阿昔洛韦耐药性复发性感染有关。